Research ExplorerPublicationsPlain language summary of isatuximab plus carfilzomib, lenal...

Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma

Standard

Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma. / Leypoldt, Lisa Beatrice; Tichy, Diana; Besemer, Britta; Hänel, Mathias; Raab, Marc S; Mann, Christoph; Munder, Markus; Reinhardt, Hans-Christian; Nogai, Axel; Görner, Martin; Ko, Yon-Dschun; de Wit, Maike; Salwender, Hans; Scheid, Christof; Graeven, Ullrich; Peceny, Rudolf; Staib, Peter; Dieing, Annette; Einsele, Hermann; Jauch, Anna; Hundemer, Michael; Zago, Manola; Požek, Ema; Benner, Axel; Bokemeyer, Carsten; Goldschmidt, Hartmut; Weisel, Katja Christina.

In: FUTURE ONCOL, 30.09.2024, p. 1-15.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Leypoldt, LB, Tichy, D, Besemer, B, Hänel, M, Raab, MS, Mann, C, Munder, M, Reinhardt, H-C, Nogai, A, Görner, M, Ko, Y-D, de Wit, M, Salwender, H, Scheid, C, Graeven, U, Peceny, R, Staib, P, Dieing, A, Einsele, H, Jauch, A, Hundemer, M, Zago, M, Požek, E, Benner, A, Bokemeyer, C, Goldschmidt, H & Weisel, KC 2024, 'Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma', FUTURE ONCOL, pp. 1-15. https://doi.org/10.1080/14796694.2024.2402639

APA

Leypoldt, L. B., Tichy, D., Besemer, B., Hänel, M., Raab, M. S., Mann, C., Munder, M., Reinhardt, H-C., Nogai, A., Görner, M., Ko, Y-D., de Wit, M., Salwender, H., Scheid, C., Graeven, U., Peceny, R., Staib, P., Dieing, A., Einsele, H., ... Weisel, K. C. (2024). Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma. FUTURE ONCOL, 1-15. https://doi.org/10.1080/14796694.2024.2402639

Vancouver

Leypoldt LB, Tichy D, Besemer B, Hänel M, Raab MS, Mann C et al. Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma. FUTURE ONCOL. 2024 Sep 30;1-15. https://doi.org/10.1080/14796694.2024.2402639

Bibtex

@article{dbf100db61f34c1ba2e9d582cdef37b9,
title = "Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma",
author = "Leypoldt, {Lisa Beatrice} and Diana Tichy and Britta Besemer and Mathias H{\"a}nel and Raab, {Marc S} and Christoph Mann and Markus Munder and Hans-Christian Reinhardt and Axel Nogai and Martin G{\"o}rner and Yon-Dschun Ko and {de Wit}, Maike and Hans Salwender and Christof Scheid and Ullrich Graeven and Rudolf Peceny and Peter Staib and Annette Dieing and Hermann Einsele and Anna Jauch and Michael Hundemer and Manola Zago and Ema Po{\v z}ek and Axel Benner and Carsten Bokemeyer and Hartmut Goldschmidt and Weisel, {Katja Christina}",
year = "2024",
month = sep,
day = "30",
doi = "10.1080/14796694.2024.2402639",
language = "English",
pages = "1--15",
journal = "FUTURE ONCOL",
issn = "1479-6694",
publisher = "Future Medicine Ltd",

}

RIS

TY - JOUR

T1 - Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma

AU - Leypoldt, Lisa Beatrice

AU - Tichy, Diana

AU - Besemer, Britta

AU - Hänel, Mathias

AU - Raab, Marc S

AU - Mann, Christoph

AU - Munder, Markus

AU - Reinhardt, Hans-Christian

AU - Nogai, Axel

AU - Görner, Martin

AU - Ko, Yon-Dschun

AU - de Wit, Maike

AU - Salwender, Hans

AU - Scheid, Christof

AU - Graeven, Ullrich

AU - Peceny, Rudolf

AU - Staib, Peter

AU - Dieing, Annette

AU - Einsele, Hermann

AU - Jauch, Anna

AU - Hundemer, Michael

AU - Zago, Manola

AU - Požek, Ema

AU - Benner, Axel

AU - Bokemeyer, Carsten

AU - Goldschmidt, Hartmut

AU - Weisel, Katja Christina

PY - 2024/9/30

Y1 - 2024/9/30

U2 - 10.1080/14796694.2024.2402639

DO - 10.1080/14796694.2024.2402639

M3 - SCORING: Journal article

C2 - 39345094

SP - 1

EP - 15

JO - FUTURE ONCOL

JF - FUTURE ONCOL

SN - 1479-6694

ER -